Global Intramedullary Nails Market Market Companies
- SuZhou Xinrong Best Medical Instrument Co., Ltd
- Jiangsu Jinlu Group Co., Ltd.
- Orthofix Inc
- AAP Implantate AG
- CarboFix Orthopedics Ltd
- Mizuho OSI, Inc
- Wuhan Dragonbio Surgical Implant Co., Ltd
- PW Medtech Group Limited
- Naton Medical Finland Oy
- Shandong Weigao Group Medical Polymer Company Limited.
Recent News:
- Strykers' new "Gamma4 (Hip Fracture Nailing System)" was unveiled in September 2022, continuing the product's 30-year history of steady innovation and clinical success. Surgeons can now use the most recent Stryker intramedullary nailing technologies with this system. The Gamma 4 technique is used to support intertrochanteric fractures, stabilize bones, and treat abnormalities of the femur bone.
- For the U.S. market, Orthofix Medical Inc. and Lima Corporate S.p.A. formed a licencing collaboration in July 2022 to provide state-of-the-art treatments to patients who suffer from high rates of chronic hip dislocation. With the use of LimaCorporates' exclusive 3D-printed pelvic fixation device, Fitbone intramedullary nail system was patented by Orthofix, a company that specializes in limb-lengthening technology. The device facilitates total hip replacement, reduces spinal strain, and corrects leg-length disparity, all of which help to have the femur repositioned by surgeons to the proper anatomical location.
- The FDA (Food and Drug Administration) authorized OrthoXel DAC's "Apex Tibial Nailing System" in January 2018. This system provides exceptional torsional stability and controlled axial micromotion, thereby facilitating secondary bone healing.